Coya Therapeutics develops treatments that target regulatory T cells, or Tregs, to treat Alzheimer's and ALS.
2
Funding Rounds
$30.0m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide